Cellular distribution of interleukin-1α-immunoreactivity after MPTP intoxication in mice

Molecular Brain Research

Volumn 138, Issue 2, 2005, Pages 156-163

  Hébert, Guillaume ^a   Mingam, Rozenn ^a   Arsaut, Josette ^a   Dantzer, Robert ^a   Demotes Mainard, Jacques ^a,b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

GAP 43; MPTP; Striatum; Substantia nigra; Tyrosine hydroxylase; Ventral tegmental area

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; INTERLEUKIN 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RODENT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; ENCEPHALITIS; GAP-43 PROTEIN; GLIOSIS; GROWTH CONES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; NERVE REGENERATION; NEURONAL PLASTICITY; PARKINSONIAN DISORDERS; TYROSINE 3-MONOOXYGENASE;

RODENTIA;

EID: 23744466228     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2005.04.019     Document Type: Article

References (50)

1. Y. Akaneya, M. Takahashi, and H. Hatanaka Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons Exp. Neurol. 136 1995 44 52
2. E. Bezard, S. Dovero, C. Imbert, T. Boraud, and C.E. Gross Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice Synapse 38 2000 363 368
3. V. Blanchard, P. Anglade, G. Dziewczapolski, M. Savasta, Y. Agid, and R. Raisman-Vozari Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra Brain Res. 709 1996 319 325
4. L.M. Bolin, I. Strycharska-Orczyk, R. Murray, J.W. Langston, and D. Di Monte Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice J. Neurochem. 83 2002 167 175
5. H.W. Cheng, J. Tong, and T.H. McNeill Lesion-induced axon sprouting in the deafferented striatum of adult rat Neurosci. Lett. 242 1998 69 72
6. J.A. Cochiolo, R. Ehsanian, and D.K. Bruck Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: evidence of compensatory plasticity in nigrostriatal neurons J. Neurosci. Res. 59 2000 126 135
7. D.I. Finkelstein, D. Stanic, C.L. Parish, D. Tomas, K. Dickson, and M.K. Horne Axonal sprouting following lesions of the rat substantia nigra Neuroscience 97 2000 99 112
8. J. Fok-Seang, N.A. DiProspero, S. Meiners, E. Muir, and J.W. Fawcett Cytokine-induced changes in the ability of astrocytes to support migration of oligodendrocyte precursors and axon growth Eur. J. Neurosci. 10 1998 2400 2415
9. A. Fontana, F. Kristensen, R. Dubs, D. Gemsa, and E. Weber Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells J. Immunol. 129 1982 2413 2419
10. J.W. Francis, J. Von Visger, G.J. Markelonis, and T.H. Oh Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in mouse striatum Neurotoxicol. Teratol. 17 1995 7 12
11. W.J. Friedman, S. Thakur, L. Seidman, and A.B. Rabson Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFkappaB J. Biol. Chem. 271 1996 31115 31120
12. D. Giulian, J. Woodward, D.G. Young, J.F. Krebs, and L.B. Lachman Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization J. Neurosci. 8 1988 2485 2490
13. J.T. Hansen, K. Sakai, J.T. Greenamyre, and S. Moran Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat Brain Res. 670 1995 197 204
14. G. Hebert, J. Arsaut, R. Dantzer, and J. Demotes-Mainard Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, a dopaminergic neurotoxin Neurosci. Lett. 349 2003 191 195
15. G. Hebert, R. Mingam, J. Arsaut, R. Dantzer, and J. Demotes-Mainard A role of IL-1 in MPTP-induced changes in striatal dopaminergic and serotoninergic transporter binding: clues from interleukin-1 type I receptor deficient mice Brain Res. Mol Brain Res. 136 2005 267 270
16. E.C. Hirsch, S. Hunot, P. Damier, and B. Faucheux Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol. 44 1998 S115 S120
17. A. Ho, and M. Blum Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice Exp. Neurol. 148 1997 348 359
18. A. Ho, and M. Blum Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease J. Neurosci. 18 1998 5614 5629
19. H. Horie, I. Sakai, Y. Akahori, and T. Kadoya IL-1 beta enhances neurite regeneration from transected-nerve terminals of adult rat DRG NeuroReport 8 1997 1955 1959
20. S. Johansson, and I. Stromberg Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon J. Comp. Neurol. 443 2002 237 249
21. K. Kaku, T. Shikimi, Y. Kamisaki, K. Shinozuka, H. Ishino, H. Okunishi, and S. Takaori Elevation of striatal interleukin-6 and serum corticosterone contents in MPTP-treated mice Clin. Exp. Pharmacol. Physiol. 26 1999 680 683
22. M. Kohutnicka, E. Lewandowska, I. Kurkowska-Jastrzebska, A. Czlonkowski, and A. Czlonkowska Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Immunopharmacology 39 1998 167 180
23. I. Kurkowska-Jastrzebska, A. Wronska, M. Kohutnicka, A. Czlonkowski, and A. Czlonkowska The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse Exp. Neurol. 156 1999 50 61
24. L.T. Lau, and A.C. Yu Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury J. Neurotrauma 18 2001 351 359
25. R. Lemke, M. Hartlage-Rubsamen, and R. Schliebs Differential injury-dependent glial expression of interleukins-1 alpha, beta, and interleukin-6 in rat brain Glia 27 1999 75 87
26. G.T. Liberatore, D.I. Finkelstein, J.Y. Wong, M.K. Horne, M.J. Porritt, G.A. Donnan, and D.W. Howells Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism Exp. Neurol. 159 1999 565 573
27. Z.D. Ling, E.D. Potter, J.W. Lipton, and P.M. Carvey Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines Exp. Neurol. 149 1998 411 423
28. S. Mandel, E. Grunblatt, and M. Youdim cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease J. Neural Transm., Suppl. 2000 117 124
29. F. Mercier, J.T. Kitasako, and G.I. Hatton Anatomy of the brain neurogenic zones revisited: fractones and the fibroblast/macrophage network J. Comp. Neurol. 451 2002 170 188
30. F. Mercier, J.T. Kitasako, and G.I. Hatton Fractones and other basal laminae in the hypothalamus J. Comp. Neurol. 455 2003 324 340
31. C. Miller, O. Tsatas, and S. David Dibutyryl cAMP, interleukin-1 beta, and macrophage conditioned medium enhance the ability of astrocytes to promote neurite growth J. Neurosci. Res. 38 1994 56 63
32. Y. Mitsumoto, A. Watanabe, A. Mori, and N. Koga Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice Biochem. Biophys. Res. Commun. 248 1998 660 663
33. M. Mogi, M. Harada, P. Riederer, H. Narabayashi, K. Fujita, and T. Nagatsu Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients Neurosci Lett. 165 1994 208 210
34. M. Mogi, A. Togari, M. Ogawa, K. Ikeguchi, N. Shizuma, D. Fan, I. Nakano, and T. Nagatsu Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum Neurosci. Lett. 250 1998 25 28
35. M. Mogi, A. Togari, K. Tanaka, N. Ogawa, H. Ichinose, and T. Nagatsu Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine- lesioned striatum in rats without influence of systemic l-DOPA on the TNF-alpha induction Neurosci. Lett. 268 1999 101 104
36. N. Nakao, T. Itakura, Y. Uematsu, M. Nakai, N. Komai, and S. Furukawa Pretreatment with interleukin-1 enhances survival of sympathetic ganglionic neuron grafts Neurol. Med.-Chir. (Tokyo) 34 1994 407 411
37. J.P. O'Callaghan, and F.J. Seidler 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of ornithine decarboxylase Neurosci. Lett. 148 1992 105 108
38. S.P. Onn, T.W. Berger, E.M. Stricker, and M.J. Zigmond Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis Brain Res. 376 1986 8 19
39. C.L. Parish, D.I. Finkelstein, W. Tripanichkul, A.R. Satoskar, J. Drago, and M.K. Horne The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice J. Neurosci. 22 2002 8034 8041
40. E.D. Potter, Z.D. Ling, and P.M. Carvey Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons Cell Tissue Res. 296 1999 235 246
41. J. Rodriguez-Pallares, H.J. Caruncho, M.J. Guerra, and J.L. Labandeira-Garcia Dipyridamole-induced increase in production of rat dopaminergic neurons from mesencephalic precursors Neurosci. Lett. 320 2002 65 68
42. E. Rousselet, J. Callebert, K. Parain, C. Joubert, S. Hunot, A. Hartmann, C. Jacque, F. Perez-Diaz, C. Cohen-Salmon, J.M. Launay, and E.C. Hirsch Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP Exp. Neurol. 177 2002 183 192
43. J. Saura, M. Pares, J. Bove, S. Pezzi, J. Alberch, C. Marin, E. Tolosa, and M.J. Marti Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity J. Neurochem. 85 2003 651 661
44. D.D. Song, and S.N. Haber Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting J. Neurosci. 20 2000 5102 5114
45. K. Sriram, J.M. Matheson, S.A. Benkovic, D.B. Miller, M.I. Luster, and J.P. O'Callaghan Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease FASEB J. 16 2002 1474 1476
46. S. Sugama, L. Yang, B.P. Cho, L.A. DeGiorgio, S. Lorenzl, D.S. Albers, M.F. Beal, B.T. Volpe, and T.H. Joh Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice Brain Res. 964 2003 288 294
47. M. Tanaka, S. Ito, and K. Kiuchi Novel alternative promoters of mouse glial cell line-derived neurotrophic factor gene Biochim. Biophys. Acta 1494 2000 63 74
48. J. Wang, K.S. Bankiewicz, R.J. Plunkett, and E.H. Oldfield Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain J. Neurosurg. 80 1994 484 490
49. D.C. Wu, V. Jackson-Lewis, M. Vila, K. Tieu, P. Teismann, C. Vadseth, D.K. Choi, H. Ischiropoulos, and S. Przedborski Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease J. Neurosci. 22 2002 1763 1771
50. A.C. Yu, and L.T. Lau Expression of interleukin-1 alpha, tumor necrosis factor alpha and interleukin-6 genes in astrocytes under ischemic injury Neurochem. Int. 36 2000 369 377